Meet with Allucent’s Experts at the ACR Convergence in Orlando!
Join Allucent at the ACR (American College of Rheumatology) Convergence, where rheumatology experts come together for insightful discussions and networking focused on the future of clinical development in the field. Dr. Mila Grieg, our VP, Medical Affairs & ACE Therapeutic Strategy Head, Immunology & Inflammation, will be attending and welcomes the opportunity to connect with peers across the rheumatology community.
Schedule a meeting with Mila at the ACR Convergence to learn more about our immunology expertise.
Fill out the form to schedule a meeting.
Attendees
Mila Grieg, MD, PhD, VP, Medical Affairs, ACE Therapeutic Strategy Head, Immunology & Inflammation
Dr. Mila Grieg is a seasoned medical professional with over 26 years of experience in the medical and clinical research fields. Holding both MD and PhD degrees, she practiced medicine for 10 years as an otolaryngologist and allergist before transitioning into clinical research. Over the past 20 years at Allucent, she has led medical execution and oversight for more than 50 Phase I-IV clinical trials, with particular expertise in immunology, as well as infectious diseases, vaccines, allergy, cardiometabolic and endocrine diseases. In her current role, Mila is ACE Therapeutic Strategy Head, Immunology & Inflammation, and Vice President, Medical Affairs, overseeing an international team of medical monitors and safety officers, ensuring the medical and clinical integrity and quality of studies conducted by Allucent.
Share This
